Genix Pharmaceuticals Corporation (TSXV:GENX)

Canada · Delayed Price · Currency is CAD

0.0200

0.00 (0.00%)

Feb 27, 2026, 9:30 AM EST

Revenue by Segment

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016
Nutraceutical and Pharmaceutical Products			12.35K				137.40K	419.96K	421.82K	924.70K
Nutraceutical and Pharmaceutical Products Growth			-				-67.28%	-0.44%	-54.38%	42.07%
Total			12.35K				137.40K	419.96K	421.82K	924.70K
Total Growth			-				-67.28%	-0.44%	-54.38%	42.07%

Revenue by Geography

Financials in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019	Oct '18 Oct 31, 2018	Oct '17 Oct 31, 2017	Oct '16 Oct 31, 2016
Canada			12.35K				137.40K	419.96K	-	530.62K
Canada Growth			-				-67.28%	-	-	2.97%
United States			-				-	-	-	394.08K
United States Growth			-				-	-	-	190.75%
Total			12.35K				137.40K	419.96K	-	924.70K
Total Growth			-				-67.28%	-	-	42.07%

Source: S&P Global Market Intelligence.